Rocket Pharmaceuticals (RCKT) Misses Q2 EPS by 2c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q2 EPS of ($0.74), $0.02 worse than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Magnolia Said In Lead To Acquire Wildfire For Over $4 Billion - Bloomberg
• FDA approves AbbVie's Skyrizi for children with psoriatic disease